Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate whether, in patients diagnosed with Vertical Heterophoria, the symptoms of dizziness, headache and / or anxiety are reduced or eliminated when a kind of correction called vertical prism is added to the patient's normal eye glass prescription.

The experiment will involve giving the patient two pairs of glasses (one pair containing the baseline prescription with vertical prism (Standard Treatment Glasses) and the other pair containing the baseline prescription but without vertical prism (Placebo Glasses)) to demonstrate which pair of glasses is most effective in reducing the symptoms of dizziness, headache and / or anxiety in these patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00785135
Study type Interventional
Source Vision Specialists of Birmingham
Contact
Status Terminated
Phase N/A
Start date November 2008
Completion date November 2015

See also
  Status Clinical Trial Phase
Completed NCT01632787 - Utility of a Survey Instrument to Predict Benefit From a Novel Treatment for Vertical Heterophoria N/A